Monsuller, Eusebio .
HRN: 28-26-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/12/2025
12/19/2025
PO
7ml
TID
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes